These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12646679)

  • 1. Mass treatment of filariasis in New Guinea.
    Addiss DG
    N Engl J Med; 2003 Mar; 348(12):1179-81; author reply 1179-81. PubMed ID: 12646679
    [No Abstract]   [Full Text] [Related]  

  • 2. Mass treatment of filariasis in New Guinea.
    Rajendran R; Sunish IP; Mani TR
    N Engl J Med; 2003 Mar; 348(12):1179-81; author reply 1179-81. PubMed ID: 12647730
    [No Abstract]   [Full Text] [Related]  

  • 3. Mass treatment to eliminate filariasis in Papua New Guinea.
    Bockarie MJ; Tisch DJ; Kastens W; Alexander ND; Dimber Z; Bockarie F; Ibam E; Alpers MP; Kazura JW
    N Engl J Med; 2002 Dec; 347(23):1841-8. PubMed ID: 12466508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards eliminating lymphatic filariasis in Papua New Guinea: impact of annual single-dose mass treatment on transmission of Wuchereria bancrofti in East Sepik Province.
    Bockarie MJ; Ibam E; Alexander ND; Hyun P; Dimber Z; Bockarie F; Alpers MP; Kazura JW
    P N G Med J; 2000; 43(3-4):172-82. PubMed ID: 11939298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic tools for filariasis elimination programs.
    Weil GJ; Ramzy RM
    Trends Parasitol; 2007 Feb; 23(2):78-82. PubMed ID: 17174604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Wolbachia treatment for lymphatic filariasis.
    Stolk WA; de Vlas SJ; Habbema JD
    Lancet; 2005 Jun 18-24; 365(9477):2067-8. PubMed ID: 15964428
    [No Abstract]   [Full Text] [Related]  

  • 7. Lymphatic filariasis: patients and the global elimination programme.
    Mackenzie CD; Lazarus WM; Mwakitalu ME; Mwingira U; Malecela MN
    Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S41-51. PubMed ID: 19843397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tropical lymphedemas--control and prevention.
    Molyneux DH
    N Engl J Med; 2012 Mar; 366(13):1169-71. PubMed ID: 22455411
    [No Abstract]   [Full Text] [Related]  

  • 9. Lymphatic filariasis in children.
    Shenoy RK
    J Commun Dis; 2006 Mar; 38(2):118-23. PubMed ID: 17370673
    [No Abstract]   [Full Text] [Related]  

  • 10. Imported bancroftian filariasis: diethylcarbamazine response and benzimidazole susceptibility of Wuchereria bancrofti in dynamic cross-border migrant population targeted by the National Program to Eliminate Lymphatic Filariasis in South Thailand.
    Bhumiratana A; Pechgit P; Koyadun S; Siriaut C; Yongyuth P
    Acta Trop; 2010 Feb; 113(2):121-8. PubMed ID: 19835831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant parasitism: bancroftian filariasis and intestinal helminths and response to albendazole.
    Sahoo PK; Satapathy AK; Michael E; Ravindran B
    Am J Trop Med Hyg; 2005 Nov; 73(5):877-80. PubMed ID: 16282297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mathematical models and lymphatic filariasis control: endpoints and optimal interventions.
    Michael E; Malecela-Lazaro MN; Kabali C; Snow LC; Kazura JW
    Trends Parasitol; 2006 May; 22(5):226-33. PubMed ID: 16564745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Could it be lymphatic filariasis?
    Leggat PA; Melrose W; Dürrheim DN
    J Travel Med; 2004; 11(1):56-60. PubMed ID: 14769289
    [No Abstract]   [Full Text] [Related]  

  • 14. Border and imported bancroftian filariases: baseline seroprevalence in sentinel populations exposed to infections with Wuchereria bancrofti and concomitant HIV at the start of diethylcarbamazine mass treatment in Thailand.
    Bhumiratana A; Koyadun S; Srisuphanunt M; Satitvipawee P; Limpairojn N; Gaewchaiyo G
    Southeast Asian J Trop Med Public Health; 2005 Mar; 36(2):390-407. PubMed ID: 15916046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A great success in lymphatic filariasis control in China. National Technical Steering Group for Filariasis Control and Research, MOPH.
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1995; 13(2):81-5. PubMed ID: 7554168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ten years of managing the clinical manifestations and disabilities of lymphatic filariasis.
    Brantus P
    Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S5-10. PubMed ID: 19843392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospects for elimination of bancroftian filariasis by mass drug treatment in Pondicherry, India: a simulation study.
    Stolk WA; Swaminathan S; van Oortmarssen GJ; Das PK; Habbema JD
    J Infect Dis; 2003 Nov; 188(9):1371-81. PubMed ID: 14593597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of annual ivermectin treatment for Wuchereria bancrofti infection.
    Plaisier AP; Stolk WA; van Oortmarssen GJ; Habbema JD
    Parasitol Today; 2000 Jul; 16(7):298-302. PubMed ID: 10858649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphatic filariasis: new insights into an old disease.
    Melrose WD
    Int J Parasitol; 2002 Jul; 32(8):947-60. PubMed ID: 12076624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long battle against a horrific disease.
    Roberts L
    Science; 2010 Feb; 327(5966):636-7. PubMed ID: 20133549
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.